Discover how NK cell therapy uses clinical-grade killer cells to target and destroy cancer safely, sharing by Dr Sergey Kulemzin
China’s Dual-Track Regulatory System: Shaping the Future of Cell Therapy Research and Commercialization Cell therapy has rapidly advanced, driven by the FDA’s 2017 approval of
Packgene’s comprehensive AAV library design services are tailored to address your specific research needs. Our AAV Library Design Expertise Our Library Design Capabilities Our commitment
1. Roadshow: Discover Cutting-Edge Translational Research Solutions Join us on October 15th 2024, 10:30 am-4:30 pm at National University of Singapore, MD-6 Centre for Translational
Atlantis Bioscience is thrilled to announce the inaugural International Cellular Therapeutics Conference (ICT Conference), happening this May 29th 2024 in Thailand! Partnering with the esteemed
For decades, the fight against cancer has relied on a three-pronged approach: surgery, radiation, and chemotherapy. While these treatments have saved countless lives, they often
Discover how substrate stiffness shapes cell behavior, tools for relevant mechanobiology, and visualize apoptosis with advanced dyes, sharing by Dr Ong Ching Yi
Explore why FBS traceability is vital in cancer research. Learn about ISIA certification and trusted serum products for reliable results.
Calling all cancer cell researchers! Are you concerned that traditional flat, plastic cell cultures might be hindering your research? This free webinar, “TUNING INTO CANCER: Exploring Substrate Stiffness and Apoptosis,” will introduce you to the exciting world of “semi-3D” cell culture and hydrogel-coated plates that can revolutionize your results by mimicking physiological conditions.
Discover current clinical trials using Mesenchymal Stem Cells (MSCs) for cancer therapy. Learn how MSCs are being studied to treat cancer and alleviate side effects of traditional therapies.
Find out strategies such as genetic engineering and modification of MSCs to enhance safety and efficacy of MSCs in cancer therapy.
Optimize stem cell cancer therapy research with Mesenchymal Stem Cells (MSCs) quality control. Ensure purity, viability, and functionality for reliable, reproducible results.
Summary The field of cancer therapy is undergoing transformative changes, driven by the following trends: iPSC-derived MSCs, MSCs-derived EVs, and Cas9-mediated gene editing in MSCs.
Microfluidics can accurately replicate complex microenvironmental and extracellular conditions found in the brain. Making it a useful tool to study glioblastoma
Mechanical forces and physical signals affect cancer cells, and studying cancer mechanobiology gives hope to new early detection, prognosis evaluation, and therapeutics.
BeCytes Biotechnologies offers a custom tissue sourcing & procurement service to acquire samples tailored to your unique research requirements. Tailored Tissue Processing Tissues in various formats upon
In recent years, chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising immunotherapy for the treatment of cancer. This therapy
Natural killer(NK) cell therapy is a cutting-edge treatment for cancer that is generating excitement in the medical world. This innovative immunotherapy harnesses the power of the body’s own immune system to fight cancer cells. In this article, we’ll explore how NK cell therapy works and what it could mean for patients with cancer.
Cancer immunotherapy has progressed tremendously in recent years, with the emergence of innovative approaches like chimeric antigen receptor (CAR) T-cell therapy and T-cell receptor (TCR)
Mesenchymal stem cells (MSCs) are adult multipotent cells that have been shown to have extraordinary anticancer properties, making them a unique option for cancer treatment.
Adoptive Cell Therapy (ACT) represents a promising approach for the treatment of cancer. It is a process in which immune cells such as T-cells
Cancer is a disease that can develop anywhere in our body as a result of excessive cell division. The location and cell types influence the etiology, symptoms, severity, and therapeutic approaches. In brain tumours, more than 75% of adults are affected by glioblastoma. The average survival rate is only two years after diagnosis, and the progression of therapeutic strategies is limited and challenging. These are mainly due to the blood-brain barrier (BBB) blockage, which makes intravenous chemotherapeutic compounds difficult to get through, and the relative rarity of this kind of cancer, which makes it difficult to attract pharmaceutical companies.
Despite CAR-T cell therapy’s clinical efficacy, it losses target antigen after therapy. NK cells have a spontaneous cytotoxic activity that is effective even when tumour antigen is downregulated.
In vitro three-dimensional (3D) cell cultures have been increasingly used for drug discovery, tissue engineering, cancer research, stem cell research and regenerative medicine.
Contact our Customer Care, Sales & Scientific Assistance
Consult and asked questions about our products & services
Documentation of Technical & Safety Data Sheet, Guides and more..